Novo Nordisk (NVO:NYSE) has boldly cut the price of its weight-loss drug Wegovy in India, making it more affordable and set to take the lead in the fast-growing obesity treatment market
Browsing: NVO
Jim Cramer shines a spotlight on Novo Nordisk A/S (NVO) as “Canada’s backdoor” in a recent Insider Monkey report, highlighting the pharma giant’s daring strategies and thrilling growth prospects throughout North America